49 results
Keyword vaxzevria Remove keyword
Type of content
News Remove News filter
Categories
Human Remove Human filter
-
List item
News: Vaxzevria: EMA advises against use in people with history of capillary leak syndrome
PRAC, Last updated: 11/06/2021Vaxzevria: EMA advises against use in … must not be vaccinated with Vaxzevria (formerly COVID-19 Vaccine … in people who had received Vaxzevria. 1 Most of the cases occurred … -
List item
News: EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome
Last updated: 07/06/2021following vaccination with Vaxzevria and COVID-19 Vaccine Janssen … following vaccination with Vaxzevria and COVID-19 Vaccine Janssen … product information for both Vaxzevria and COVID-19 Vaccine Janssen … -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021Vaxzevria: further advice on blood clots … occurring after vaccination with Vaxzevria (formerly COVID-19 Vaccine … professionals: must not give Vaxzevria to anyone who has had blood … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 May 2021
CHMP, Last updated: 21/05/2021COVID-19: Vaxzevria: further advice on blood clots … occurring after vaccination with Vaxzevria (formerly COVID-19 Vaccine … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021
PRAC, Last updated: 07/05/2021that has been reported in Vaxzevria and COVID-19 vaccine Janssen … clinical pattern observed with Vaxzevria and COVID-19 Vaccine Janssen … summary safety reports for Vaxzevria, AstraZeneca’s Covid-19 … -
List item
News: AstraZeneca’s COVID-19 vaccine: benefits and risks in context
CHMP, Last updated: 23/04/2021News 23/04/2021 Vaxzevria (formerly COVID-19 Vaccine … healthy people. The benefits of Vaxzevria outweigh its risks in adults … Known benefits and risk of Vaxzevria … -
List item
News: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 20/04/2021developed by AstraZeneca, Vaxzevria. Healthcare professionals … another COVID-19 vaccine, Vaxzevria (previously COVID-19 Vaccine … developed by AstraZeneca, Vaxzevria. As for the mechanism, it … -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
CHMP, Last updated: 14/04/2021after vaccination with Vaxzevria (previously COVID-19 Vaccine … authorities to put the risks of Vaxzevria into the context of the benefits … recommendations for a second dose of Vaxzevria in those who have already … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021
PRAC, Last updated: 09/04/2021low blood platelets with Vaxzevria (AstraZeneca’s COVID-19 … very rare side effects of Vaxzevria (previously COVID-19 Vaccine … capillary leak syndrome with Vaxzevria (AstraZeneca’s COVID-19 … -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 07/04/2021very rare side effects of Vaxzevria (formerly COVID-19 Vaccine … beyond the site of injection Vaxzevria is one of four vaccines authorised … occurred in people who received Vaxzevria (formerly COVID-19 Vaccine … -
List item
News: AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
PRAC, Last updated: 31/03/2021COVID-19 vaccine (now called Vaxzevria) . EMA convened an ad hoc … and hospitalisation rates. Vaxzevria (previously COVID-19 Vaccine … Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
CHMP, Last updated: 26/03/2021COVID-19 Vaccine Moderna): EPAR Vaxzevria (previously COVID-19 Vaccine … -
List item
News: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
PRAC, Last updated: 25/03/2021people vaccinated with Vaxzevria (previously COVID-19 Vaccine … -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021people vaccinated with Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
PRAC, Last updated: 16/03/2021platelets, in recipients of Vaxzevria (previously COVID-19 Vaccine … -
List item
News: EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update
PRAC, Last updated: 15/03/2021paused vaccination with Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021
PRAC, Last updated: 12/03/2021reported post-vaccination with Vaxzevria (previously COVID-19 Vaccine … -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update
PRAC, Last updated: 11/03/2021vaccination campaign with Vaxzevria (previously COVID-19 Vaccine … European Economic Area (EEA) Vaxzevria (previously COVID-19 Vaccine … Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 Vaccine … -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
PRAC, Last updated: 10/03/2021suspended the use of a batch of Vaxzevria (previously COVID-19 Vaccine … Lithuania, Luxembourg, Latvia Vaxzevria (previously COVID-19 Vaccine … Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers
CHMP, Last updated: 25/02/2021COVID-19 Vaccine Moderna) and Vaxzevria (previously COVID-19 Vaccine … -
List item
News: EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
Last updated: 29/01/2021Vaxzevria (previously COVID-19 Vaccine … Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 Vaccine … -
List item
News: EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
Last updated: 12/01/2021Vaxzevria (previously COVID-19 Vaccine … Vaccine AstraZeneca): EPAR Vaxzevria (previously COVID-19 Vaccine … -
List item
News: Update on rolling review of AstraZeneca’s COVID-19 vaccine
Last updated: 30/12/2020The vaccine, called Vaxzevria (previously COVID-19 Vaccine … cells and cause disease. Vaxzevria (previously COVID-19 Vaccine … -
List item
News: EMA starts first rolling review of a COVID-19 vaccine in the EU
Last updated: 01/10/2020The vaccine, called Vaxzevria (previously COVID-19 Vaccine … cells and cause disease. Vaxzevria (previously COVID-19 Vaccine …